Peak 2017 memorabilia
Release time:
2020-08-14
Peak 2017 Major events
1# July
1# November 4 At the 6th member congress of Jinhua Federation of Industry and Commerce, Jiang Xiaomeng, chairman of the group company, was elected chairman of Jinhua Federation of Industry and Commerce and was commended as "2016 Xinyi Good Wushang.
September , the group company held the 2016 annual summary commendation conference.
2017 1 1 , with a time of five years.
September
March 28 , the board of directors of the group company deliberated and approved the phased investment proposal of Jianfeng pharmaceutical to Beijing huibaoyuan biotechnology co., ltd. the Jianfeng pharmaceutical industry will take Beijing huibaoyuan and its controlling subsidiary Guangxi huibaoyuan as the platform to jointly carry out new drug research and development, drug production and management and other businesses.
2013 and 2016 .
1 Class New Drug DPT (Deoxypodophyllotoxin) clinical application was approved by the State Food and Drug Administration.
21 , Yunnan Jianfeng Cement Company passed the review and acceptance of the second-level enterprise of safety production standardization.
June 25 , the 5th Member Congress and the 5th First Council of Zhejiang Building Materials Industry Association were held in Jinhua. Jiang Xiaomeng, chairman of the group company, was elected as the new president.
February
June 27 , Wu Guangjun, electrical director of Jinxi Factory of Pharmaceutical Company, was awarded the title of "Ba Wu Craftsman" at the first Ba Wu Craftsman Naming Conference in Jinhua City.
August
, 105 and ended on December 1, 106. 5# November 20 , Jinhua Federation of Trade Unions, Economic and Information Commission Working Committee and Jianfeng Group jointly sponsored the Jianfeng Group Staff Fun Games hosted by the Municipal Workers' Cultural Palace held in Jinhua Gymnasium.
July 6 January
day, peak pharmacy micro-mall began trial operation.
7
7 April
, the party Committee of the group company organized more than 80 party members of the in the gold enterprise to visit the former residence of Chen wangdao, the first generation of communist fighters in China and the first translator of the communist manifesto in Chinese, to remember the deeds of the revolutionary ancestors and relive their beliefs.
7 February 13 , the "Strategic Alliance for Technological Innovation in Plant Waste Reuse Industry" was formally established with Tianjin Jianfeng Natural Products Company as the chairman unit.
August 14 at the 11th Congress of Zhejiang Federation of Industry and Commerce, Chairman Jiang Xiaomeng was elected Vice President of Zhejiang Chamber of Commerce and Representative of the 12th Congress of the All-China Federation of Industry and Commerce.
8 July
8 January
, daye peak cement company desulfurization project started.
company video conference system upgrade completed.
March
daye peak won the title of "best integrity enterprise" in daye city. This is the city's first selection, recognition of integrity enterprises.
Daye Peak and Yunnan Peak both won the "Full Excellence Award" in the 16th National Cement Quality Index Test of "Hongchao Science and Technology Cup" in 2017 ".
10
10 September
, Yunnan Jianfeng Ton Packed Cement went abroad for the first time and was sent to Laos.
May 18 , the 19th National Congress of the Communist Party of China opened in Beijing. The Party Committee of the Group organized all senior executives, Party members and Party activists to watch the opening meeting.
19 , the company 2016
to 2017 9 November "three" cultivation project implementation work successfully passed the phased acceptance. 10 May 26 , the company organized fire training, fire evacuation and fire fighting drills in Peak Building.
Company ranked among the "2017 China Building Materials Enterprises
" in the industry joint selection organized by China Building Materials Federation, China Building Materials Enterprise Management Association, China Building Materials Industry Planning and Research Institute and other units ".
November 23 January Peak Pharmaceutical's key product Lestat (Amlodipine Aspartate Tablets) was named "2017 China's Most Growing Product" at the
National Pharmaceutical Economic Information Conference ".
February 16 , the company held a general meeting of shareholders to elect the board of directors and the board of supervisors. The new board of directors and the board of supervisors held their first meeting and elected Jiang Xiaomeng as the chairman of the new (10th) board of directors, Chen Tianci as the chairman of the new (9th) board of supervisors, the board of directors appointed the new management team and Yu Jianhong as the general manager of the company. November
12 to 18 , Yunnan Jianfeng Cement Company held the second "Jianfeng Cup" basketball invitational tournament, with representatives of 12
November 25 August 24 to 26 , Chairman Jiang Xiaomeng of the Group Company went to Beijing to attend the 12th National Congress of the China Federation of Industry and Commerce.
Peak Pharmaceutical renewed Wang Guangji, academician of the Chinese Academy of Engineering, as chief scientist. December February
Peak Pharmaceutical was recognized by the State Intellectual Property Office as the "National Intellectual Property Demonstration Enterprise" of
".
Company was rated as an advanced unit in Jinhua City.
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31